MetaADEDB 2.0 @ LMMD
xaliproden
(WJJYZXPHLSLMGE-UHFFFAOYSA-N)
Structure
SMILES
FC(c1cccc(c1)C1=CCN(CC1)CCc1ccc2c(c1)cccc2)(F)F
Type(s)
Investigational
ATC code(s)
N07XX03
Molecular Formula:
C24H22F3N
Molecular Weight:
381.433
Log P:
6.1283
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
0
TPSA:
3.24
CAS Number(s):
90494-79-4; 135354-02-8
Synonym(s)
1.
xaliproden
2.
1-(2-(naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride
3.
1-(2-(naphth-2-yl)ethyl)-4-(trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride
4.
SR 57746A
5.
SR-57746A
6.
SR57746A
7.
xaliproden hydrochloride
External Link(s)
MeSHC462299
PubChem Compound128919
BindingDB82363
ChEBI48520
CHEMBLCHEMBL1512580
DrugBankDB06393
KEGGdr:D06327
Therapeutic Target DatabaseD02OJC
ZINC577115
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Brain Injuries8413926CTD
2Nerve Degeneration8413926CTD
3Neurobehavioral Manifestations8413926CTD
4Peripheral Nervous System Diseases8413926CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.